ArticleDiscover oncology2025

Hsa_circ_0062522 affects the progression and tamoxifen resistance of estrogen receptor-positive breast cancer by targeting miR-3163.

Yan Bian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.